Iio Etsuko

Affiliation and department：

Research field (1)： Gastroenterology

Research keywords (3)：肝線維化 , 肝癌 , 肝炎ウイルス

Research theme for competitive and other funds (1)：

2019 - 2023 HBV遺伝子のヒト遺伝子への組み込みに対する統合的遺伝子解析から肝発癌を予測する

Papers (109)：

Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura, Kyoko Ito, Shintaro Ogawa, Hayato Kawamura, Kei Fujiwara, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, et al. MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Journal of gastroenterology. 2024
Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura, Hayato Kawamura, Kei Fujiwara, Shintaro Ogawa, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, Hiromi Kataoka, et al. Serum angiopoietin-2 levels predict the development of hepatocellular carcinoma following hepatitis C virus eradication using direct-acting antiviral agents. Oncology. 2024
井上貴子, 大西雅也, 飯尾悦子, 渡邊丈久, 田中靖人. C型肝炎ウイルス排除前後の便中胆汁酸組成から見た腸内環境の特徴と病態との関連. 肝臓. 2023. 64. Suppl.2. A610-A610
Yoshihito Nagura, Takanori Suzuki, Kentaro Matsuura, Shintaro Ogawa, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Katsuya Nagaoka, Etsuko Iio, et al. Serum inducible protein 10 kDa/C-X-C motif chemokine 10 levels predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Hepatology research : the official journal of the Japan Society of Hepatology. 2023
Yu Jun Wong, Sally Tran, Chung-Feng Huang, Yao-Chun Hsu, Carmen Preda, Hidenori Toyoda, Joanne Liu, Dae Won Jun, Charles Landis, Daniel Q Huang, et al. Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study. Hepatology international. 2023

ｍore...

MISC (49)：

井上貴子, 鈴木孝典, 飯尾悦子, 渡邊丈久, 長岡克弥, 吉丸洋子, 瀬戸山博子, 立山雅邦, 田中靖人. ウイルス性慢性肝炎患者における甲状腺機能障害有病率の現状. 肝臓. 2022. 63. Suppl.3. A772-A772
井上貴子, 大西雅也, 守屋圭, 瓦谷英人, 飯尾悦子, 松浦健太郎, 吉治仁志, 田中靖人. HCV排除による腸内環境と胆汁酸代謝酵素遺伝子発現量の変化. 肝臓. 2022. 63. Suppl.2. A552-A552
Fanpu Ji, Eiichi Ogawa, Chung-Feng Huang, Hidenori Toyoda, Yu Jun Wong, Etsuko Iio, Dae Won Jun, Li Liu, Haruki Uojima, Akito Nozaki, et al. REAL-WORLD EFFECTIVENESS AND SAFETY OF INTERFERON-FREE DAAS FOR 14,676 HEPATITIS C (CHC) PATIENTS WITH GENOTYPES 1, 2, 3, 4 AND 6: A MULTINATIONAL STUDY. HEPATOLOGY. 2021. 74. 579A-581A
井上貴子, 守屋圭, 瓦谷英人, 飯尾悦子, 松浦健太郎, 藤原圭, 吉治仁志, 田中靖人. C型肝炎ウイルス排除後の糖代謝に関与する腸内フローラの特徴. 糖尿病. 2021. 64. Suppl.1. LDP-6
井上貴子, 瓦谷英人, 守屋圭, 飯尾悦子, 伊藤清顕, 松浦健太郎, 藤原圭, 米田政志, 吉治仁志, 田中靖人. C型慢性肝炎患者にみられる腸内フローラ異常(dysbiosis)の増悪因子と腸内代謝物との関連. 日本消化器病学会雑誌. 2020. 117. 臨増総会. A210-A210

ｍore...

Professional career (1)：

医学博士 (名古屋市立大学大学院医学研究科)

Work history (2)：

2022/09 - 現在 Kumamoto University
2009/04 - 2020/06 Nagoya City University

Awards (4)：

2020/08 - The 33th Japanese Society of Gastroenterology Award for Encouragement TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy(J. Gastroenterol 2019; 54: 339-346)
2020/08 - The 12th Journal of Gastroenterology High Citation Award Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1.
2016/05 - Presidential Awards
2016 - APASL 2016 Young Investigator Award

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page